Virbac: 15% sales growth in H1

(CercleFinance.com) - Virbac posted sales growth of 15.
2% to E703.1 million for the first half of 2024 (+16.2% at constant exchange rates), boosted by the integration of recently acquired companies (Globion in India and Sasaeah in Japan) to the tune of +4.9 points.

At constant exchange rates and scope of consolidation, growth for the animal health group reached +11.3%, driven by the concomitant increase in volumes and prices (price effect estimated at around 3.5 points) despite a slowdown in inflation.

Virbac confirms its annual targets, on a like-for-like basis and at constant exchange rates, of sales growth of 7% to 9%, and an adjusted operating profit on sales ratio of around 16%.


Copyright (c) 2024 CercleFinance.com. All rights reserved.